Abstract:Vasculitis, a group of systemic inflammatory diseases that affect the cardiovascular (CV) system, presents with a variety of clinical manifestations that depend on the size of the affected blood vessels. While some types of vasculitis reveal distinct symptoms, others are characterized by more diffuse and nonspecific presentations that can result in delayed diagnosis and treatment initiation. Interestingly, patients with vasculitides share a significant comorbidity: an elevated CV risk, contributing to increased rates of CV events and mortality. This heightened risk is caused by cumulative inflammatory burden, traditional CV risk factors, medication effects, and reduced physical fitness. Traditional risk assessment tools, commonly used in the general population, frequently underestimate the CV risk in patients with inflammatory rheumatic conditions. Consequently, novel approaches are necessary to stratify the precise CV risk in vasculitis patients. A number of surrogate parameters for CV risk have been investigated, with arterial stiffness emerging as a promising marker. Pulse wave velocity (PWV) is a well-established method for assessing arterial stiffness and predicting CV risk across different populations. Among numerous PWV variants, carotid-femoral PWV (cfPWV) stands out as the most extensively studied and accepted reference standard. It has demonstrated its utility as a surrogate CV parameter both in the general population and in patients with systemic inflammatory rheumatic diseases. In recent years, research has expanded to assess arterial stiffness in systemic rheumatic diseases, such as arthritis, connective tissue diseases, rheumatologic overlap syndromes, and chronic pain disorders, using measurements of PWV and other markers of arterial compliance and elasticity. Despite burgeoning research in rheumatologic diseases, data on CV risk markers in vasculitides remain limited and fragmented. This narrative review aims to provide a comprehensive overview of arterial stiffness as a potential screening marker for CV diseases, atheromatosis, and ultimately CV risk among patients with vasculitides.

Arterial Stiffness: From Basic Primers to Integrative Physiology

Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease

Arterial Stiffness and Hypertension in the Elderly

Paradigms of endothelial stiffening in cardiovascular disease and vascular aging

Arterial Stiffness in Hypertension and Function of Large Arteries

Cellular and Molecular Determinants of Arterial Aging

Vascular Stiffness in Aging and Disease

Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases

Multiscale Mechanical Behavior of Large Arteries

Aortic and arterial mechanics

Age-Associated Dysregulation of Integrin Function in Vascular Smooth Muscle

Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women.

Fresh Insight into Vascular Disease: Arterial Stiffness, Pulse Wave and Pulse Pressure

The Substrate Stiffness at Physiological Range Significantly Modulates Vascular Cell Behavior.

Arterial Stiffening Provides Sufficient Explanation for Primary Hypertension

Role of cellular mechanics in the function and life span of vascular endothelium

Biomechanical Phenotyping of Central Arteries in Health and Disease: Advantages of and Methods for Murine Models

Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Vasculitides: A Literature Review

Arterial Stiffness and Stroke: De-Stiffening Strategy, a Therapeutic Target for Stroke

Pulmonary Vascular Stiffness: Measurement, Modeling, and Implications in Normal and Hypertensive Pulmonary Circulations

Aging impairs smooth muscle-mediated regulation of aortic stiffness: a defect in shock absorption function?